Coronary

 Course Objective

CCT2022 will be held for 3 days from Thursday, October 27 to Saturday, October 29, 2022. Last year, CCT2021 was held as a virtual meeting by considering the situation of COVID-19 pandemic. At this point, there is a possibility of holding the meeting on site this autumn; therefore, we are planning to host it as a hybrid style meeting of webcast and on site for domestic attendees, and primarily as a virtual meeting for international attendees. However, the meeting format is subject to change to a virtual event for all attendees depending on the situation of COVID-19 pandemic.

The Complex PCI procedure has been rapidly improved about these 20 years and reached its maturity today. Nevertheless, there is a possibility of a drastic change in the Complex PCI procedure in the future, since new improvements are still coming. For bifurcation lesions and calcified lesions, we are becoming able to apply a variety of debulking devices by introducing a high-resolution evaluation method mainly based on OCT. In addition, for CTO lesions, more accurate and effective procedure is now possible because an angiography puncture method by using a new penetration plane view and a puncture method by using IVUS which is specialized to CTO have developed, as well as a wire with more penetration ability has been developed and become available. In CCT2022, we aim to progress the level of complex PCI procedure worldwide by presenting all the way from educational and basic techniques to these updated knowledge and procedures.

We sincerely hope the situation of COVID-19 pandemic settles down in autumn, 2022 so that we are able to see many of you on site or on the web. Your active participation is very much appreciated.

Atsunori Okamura
CCT2022 Representative Coronary Course Director

 Program


English
Updated: September 20, 2022

Japanese
Updated: August 30, 2022

Fellow Course: Bifurcation

Thursday, October 27 8:30-10:30 (JST) Room 4

Coordinator: Hiromasa Katoh (Fukui Prefectural Hospital)

Bifurcation lesions account for approximately 20% of PCI procedures and are among the most commonly encountered complex lesions in daily clinical practice. This means that even young operators who are just starting out on their own are often forced to deal with bifurcation lesions in emergency situations. Although various treatment strategies have been devised and tested for bifurcation lesions, the procedures are still more complicated than those for non-bifurcation lesions, and the short- and long-term outcomes are still not satisfied. Therefore, each institution probably has its own strategies, and young operators often follow these. In this session, tips and logic in bifurcation treatment will be delivered by experienced doctors who are active at the forefront of the field, including their own experiences, in accordance with each theme. We believe that this session will be useful not only for young doctors who are starting bifurcation PCI, but also for mid-career doctors who would like to deepen their understanding of this treatment. We hope that many of you will join us to learn more about bifurcation PCI together.

Fellow Course: Complications

Thursday, October 27 10:30-12:30 (JST) Room 4

Coordinator: Takeshi Niizeki (Okitama Public General Hospital)

I am pleased to be in charge of organizing a session of "Complications” as the CCT2022 Fellow Course. As long as you are involved in PCI, there will be times when you will encounter some complications or have to cross a dangerous bridge even if it does not lead to a complication. Therefore, it is very important to accurately predict and prevent the risk of complications, and to bail out quickly if a complication does occur. We believe that this session will be very useful for young doctors by sharing the valuable experiences and thoughts of experts with a wealth of experience in PCI. We believe that a bail-out procedure that you have seen or heard of once may save a patient's life. We look forward to your active participation.

How to treat the difficult ACS cases with interventional techniques and devices

Thursday, October 27 10:30-12:30 (JST) Room 5

Coordinator: Hiroyuki Tanaka (Kurashiki Central Hospital)

There are several difficult ACS cases to treat with interventional techniques, such as the existence of huge thrombus, severe calcified lesions, triple vessels, and cardiac shock. In this session, the expert operators will inform you about an effort to shorten the door-to-balloon time, and the interventional techniques including the latest ones to overcome difficult situations. Furthermore, the discussions during the session will make these solutions clearer for the difficult ACS situations.

LMT PCI

Thursday, October 27 14:00-16:00 (JST) Room 5

Coordinator: Maoto Habara (Toyohashi Heart Center)

Percutaneous coronary intervention (PCI) of left main trunk (LMT) lesions has shown better results than in the past as device technology and catheterization techniques have improved. As a result of the accumulation of clinical data, PCI for LTM is now considered an alternative therapy to coronary artery bypass graft surgery (CABG), which was previously considered an unconditional first-line procedure, and is now widely used in daily practice. However, the treatment of LMT lesions is of great importance in terms of prognosis, and even now that devices and techniques are becoming more mature, our mission is to select the optimal treatment strategy for each patient and lesion and to optimize it to the maximum extent possible. In this session, we will focus on LMT-PCI and discuss how to make full use of the various devices currently available in Japan to achieve good outcomes. We hope that you will be able to get some hints for your own LMT PCI in the future.

Calcified lesion

Thursday, October 27 16:00-18:00 (JST) Room 5

Coordinator: Tomoko Kobayashi (Kyoto Katsura Hospital)

Severe calcification is a strong predictor of poor clinical outcomes after PCI. To solve this problem, we should know the specificity of calcified plaque and make full use of special devices and technique. The rotablator has been used for more than 25 years and OAS has been authorized for about 5 years. Recently users of these atherectomy devices have been increasing and the usage has been changed. In this session, we can update the rotablator or OAS usage and get knowledge of the newest device “IVL” to improve clinical outcomes after PCI for calcified lesions.

Fellow Course: CTO

Friday, October 28 8:30-10:30 (JST) Room 4

Coordinator: Katsuyuki Hasegawa (Higashi Takarazuka Satoh Hospital)

In the past, when CTO-PCI was "a divine art that only masters could perform," the audience watched the masters’ performance at the CTO live demonstrations with bated breath. Over time, the success rate of CTO-PCI improved with advances in devices and techniques, and the CTO lesion became a subject for operators with a certain level of experience to deal with. On the other hand, CTO lesions are still representative of complex lesions and are a formidable opponent that cannot be treated "haphazardly" or "in an improvised manner”. In this session, we will provide the indispensable essentials as well as knowledge and techniques to confront CTO lesion that are one-size-fits-all for young doctors who are ready to start CTO-PCI. We believe that this session will be useful for mid-career doctors and co-medical staffs who want to deepen their understanding of CTO-PCI. We look forward to seeing many participants.

Clinical IVUS Course

Friday, October 28 8:30-10:00 (JST) Room 5

Coordinator: Kazuhiro Ashida (Seirei Yokohama Hospital)

Just as it is difficult to steer a car if you don't know which direction to drive in, so in PCI, visualization is essential to navigate the treatment in the right direction, and IVUS can help with this. In complex PCI using DCA/RA/OAS, IVUS plays an important role in guiding the reason for selecting each device, and the direction and method of modification. In CTO lesions, where it is difficult to understand the accurate vascular geometry in the first place, the need for IVUS is increasing, and IVUS is evolving and becoming more sophisticated, not only by using conventional IVUS guide techniques but also by using 3D wiring, and so on.

In this session, speakers who are experts in the use of IVUS in complex PCI will give lectures including tips and tricks on each topic and discuss them in depth. Let's deepen our understanding of IVUS as it relates to the essence of Complex PCI and apply it to your practice from now on.

Fellow Course: Physiology

Friday, October 28 10:30-12:30 (JST) Room 4

Coordinator: Shoichi Kuramitsu (Kokura Memorial Hospital)

FFR and NHPR are now indispensable for PCI because they are widely used to evaluate ischemia in coronary lesions, and to determine treatment strategies and therapeutic efficacy. Recently, coronary physiology has been advancing rapidly, showing that coronary microvascular disease has drawn attention, and angiography- and IVUS/OCT-derived FFR have emerged. However, it is also true that it has become difficult to organize the knowledge of coronary physiology. In this session, we have planned a program that will be immediately useful in clinical practice by having experts talk about everything from how to utilize physiology-guided PCI to the latest topics. We hope that young doctors and everyone who wants to study coronary physiology will join this session. We look forward to studying coronary physiology together!

DCA

Friday, October 28 14:00-15:20 Room 5

Coordinators: Takeshi Niizeki (Okitama Public General Hospital), Yuji Oikawa (The Cardiovascular Institute)

I am pleased to be in charge of planning the CCT2022 "DCA" session together with Dr. Oikawa. Since DCA has been revived, the awareness of DCA has gradually increased and the evidence has been established. However, it is said that only about 1% of all elective PCIs are truly necessary to apply DCA, and the frequency is low. In this regard, you also experience some cases in which complex stenting can be avoided and a favorable long-term prognosis can be expected by performing DCA. This year, same as the previous year, we would like to study DCA procedures as video live session together with you, focusing on the recent topics of "DCA from Radial" and "DCA using Tip detection method" to deepen our knowledge of DCA. We are looking forward to your active participation in this seminar, which will be useful for your clinical practice.

Fellow Course: Mastering “IVUS/OCT/OFDI”

Saturday, October 29 8:30-10:10 (JST) Room 4

Coordinator: Atsushi Funatsu (Kyoto Katsura Hospital)

Currently, PCI using intravascular imaging devices is performed in many cases. However, are we fully understanding and utilizing the obtained imaging findings for the treatments? In this session, experts will discuss the basics of IVUS/OCT/OFDI and its application to the treatments, allowing PCI beginners to deepen their knowledge of intravascular imaging and intermediate and advanced operators to further brush up on their existing knowledge. We hope that you are able to aim for a high-quality PCI with full utilization of intravascular imaging.

Retrograde

Saturday, October 29 8:30-10:00 (JST) Room 5

Coordinators: Wataru Nagamatsu (Hokusetsu General Hospital), Takafumi Tsuji (Kusatsu Heart Center)

The retrograde technique has reached its maturity. In this session, we will discuss the current indications for retrograde procedures and share the tips via pre-recorded procedure video. In addition, the standardization of channel evaluation, prevention and treatment of complications which are key elements of retrograde procedures, and the definition and classification of Reverse CART are in progress. We will offer the lectures regarding these topics in this session. We look forward to your active participation.

Fellow Course "Overcoming Calcified Lesions"

Saturday, October 29 14:00-16:00 (JST) Room 4

Coordinator: Ken Ishibashi (Tsuchiya General Hospital)

We are at a time when PCI is being required with fewer complications, however, at the same time, it is a fact that the need for PCI for critical ischemic heart disease is increasing due to the aging of the population. One of the Achilles heels is calcified lesions, for which devices such as Rotablator and Diamondback have been used. Now that more than two years have passed since the change in facility standards and more facilities are able to use these specialized catheters, there is a need to share safe and effective treatment strategies. In this course, we have prepared lectures on the concept of calcified lesions from the pathological point of view, in addition to the lectures on the basic usage of these two debulking devices and the effective usage of imaging. We are also planning to discuss cases of complications. This course is intended for those who want to relearn the basics as well as for those who are new to the use of devices. We look forward to your active participation.

Mechanical Circulatory Support for Cardiogenic Shock in ACS

Saturday, October 29 14:00-16:00 (JST) Room 5

Coordinator: Hiroyuki Tanaka (Kurashiki Central Hospital)

The use of mechanical circulatory support (MCS) devices is considered for cardiogenic shock in acute coronary syndrome (ACS). Currently, the percutaneous MCS devices such as IABP, IMPELLA and ECMO have been available as a bridge to recover in patients with cardiogenic shock in ACS, and it is required to properly use each support device according to several pathological conditions.

In this session, the expert operators will inform you about the latest findings of the IMPELLA device to overcome cardiogenic shock. Furthermore, we would like to discuss cardiogenic shock in ACS through the IMPELLA video live, the pathological conditions that each support device can be adapted to, the best timing for the introduction of various support devices, and the combinations according to pathological conditions.

 Honorary Advisors

Yasushi Asakura
(Yamato Tokushukai Hospital)

Keiichi Igarashi Hanaoka
(Hanaoka Seishu Memorial Hospital)

Tomoaki Hinohara
(Sequoia Hospital, USA)

Osamu Katoh
 

Mikihiro Kijima
(Hoshi General Hospital)

Eisho Kyo
(Kusatsu Heart Center)

Satoru Otsuji
(Higashi Takarazuka Satoh Hospital)

Takahiko Suzuki
(Toyohashi Heart Center)

Kinzo Ueda
(Takase Memorial Hospital)

Masahisa Yamane
(Saitama Sekishinkai Hospital)

 Coronary Course Directors

Kazuhiro Ashida
(Seirei Yokohama Hospital)

Maoto Habara
(Toyohashi Heart Center)

Ichiro Hamanaka
(Rakuwakai Marutamachi Hospital)

Yuji Hamazaki
(Ootakanomori Hospital)

Yasumi Igarashi
(Sapporo-Kosei General Hospital)

Ken Ishibashi
(Tsuchiya General Hospital)

Kaoru Iwabuchi
(Osaki Citizen Hospital)

Hiromasa Katoh
(Fukui Prefectural Hospital)

Tomohiro Kawasaki
(Shin-Koga Hospital)

Yoshihisa Kinoshita
(Toyohashi Heart Center)

Tomoko Kobayashi
(Kyoto Katsura Hospital)

Shunsuke Matsuno
(The Cardiovascular Institute)

Wataru Nagamatsu
(Hokusetsu General Hospital)

Kenya Nasu
(Mie Heart Center)

Takeshi Niizeki
(Okitama Public General Hospital)

Yuji Oikawa
(The Cardiovascular Institute)

Atsunori Okamura
(Sakurabashi Watanabe Hospital)

Junya Shite
(Osaka Saiseikai Nakatsu Hospital)

Hiroyuki Tanaka
(Kurashiki Central Hospital)

Etsuo Tsuchikane
(Toyohashi Heart Center)

Takafumi Tsuji
(Kusatsu Heart Center)

Junji Yajima
(The Cardiovascular Institute)

Masaru Yamaki
(Nayoro City General Hospital)

Ryohei Yoshikawa
(Sanda City Hospital)

 International Faculty

Suko Adiarto
(National Cardiovascular Center Harapan Kita Hospital, Indonesia)

Jung-Min Ahn
(Asan Medical Center, Korea)

Taehoon Ahn
(Gachon University Gil Hospital, Korea)

I Made Junior Rina Artha
(Sanglah General Hospital, Indonesia)

Jang-Whan Bae
(Chungbuk National University Hospital, Korea)

Emmanouil Brilakis
(Minneapolis Heart Institute, USA)

Long Bui
(Hanoi Friendship Hospital, Vietnam)

In-Ho Chae
(Seoul National University Bundang Hospital, Korea)

Alan Ka Chun Chan
(Queen Elizabeth Hospital, Hong Kong)

Karl Chi Yuen Chan
(Grantham Hospital, Hong Kong)

Yu-Ho Chan
(The CUHK Medical Centre, Hong Kong)

Chi-Jen Chang
(Chang Gung Memorial Hospital, Linkou, Taiwan, R.O.C.)

Shih-Sheng Chang
(China Medical University Hospital, Taiwan, R.O.C.)

Jiyan Chen
(Guangdong Provincial People's Hospital, Institute of Cardiovascular Diseases, People's Republic of China)

Cheng-I Cheng
(Kaohsiung Chang Gung Memorial Hospital, Taiwan, R.O.C.)

Chee Yang Chin
(National Heart Centre, Singapore)

Ki Hong Choi
(Samsung Medical Center, Korea)

Antonio Colombo
(EMO GVM Centro Cuore Columbus, Milan/Humanitas Research Hospital, Rozzano, Italy)

Rajesh M. Dave
(Holy Spirit Cardiovascular Institute, USA)

Tony DeMartini
(Memorial Medical Center, USA)

Zhi-Min Du
(Sun Yat-Sen University, First Affiliated Hospital, People's Republic of China)

Mohaned Egred
(Newcastle’s Freeman Hospital, U.K.)

Sarah Fairley
(Wellington Hospital, New Zealand)

Ching-Chang Fang
(Tainan Municipal Hospital, Taiwan, R.O.C.)

Hsiu-Yu Fang
(Chang Gung Memorial Hospital, Kaohsiung, Taiwan, R.O.C.)

Aloke Finn
(CVPath Institute, Inc., USA)

Doni Firman
(National Cardiovascular Center Harapan Kita Hospital, Indonesia)

Andrea Gagnor
(ASL Citta di Torino, Maria Vittoria Hospital, Italy)

Run-Lin Gao
(Fu Wai Hospital, People's Republic of China)

Roberto Garbo
(Maria Pia Hospital, GVM Care & Research, Italy)

Junbo Ge
(Zhongshan Hospital, Fudan University, People's Republic of China)

Lei Ge
(Zhongshan Hospital, Fudan University, People's Republic of China)

Pravin K. Goel
(Medanta Heart Institute, India)

Yew Seong Goh
(Changi General Hospital, Malaysia)

Hyeon-Cheol Gwon
(Samsung Medical Center, Korea)

Joo-Yong Hahn
(Samsung Medical Center, Korea)

Kyoo Rok Han
(Hallym University, Kangdong Sacred Heart Hospital, Korea)

Scott Andrew Harding
(Wellington Hospital, New Zealand)

Ben He
(Shanghai Chest Hospital, People's Republic of China)

Van Hoang
(Hanoi Heart Hospital, Vietnam)

Myeong-Ki Hong
(Yonsei University College of Medicine, Severance Hospital, Korea)

I-Chang Hsieh
(Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou, Taiwan, R.O.C.)

Jung-Cheng Hsu
(Far Eastern Memorial Hospital, Taiwan, R.O.C.)

Chi-Hung Huang
(Cathay General Hospital, Taiwan, R.O.C.)

Chien-Ming Huang
(Cheng Hsin General Hospital, Taiwan, R.O.C.)

Ching-Chang Huang
(National Taiwan University Hospital, Taiwan, R.O.C.)

Shao-Sung Huang
(Taipei Veterans General Hospital, Taiwan, R.O.C.)

Wei-Chun Huang
(Kaohsiung Veterans General Hospital, Taiwan, R.O.C.)

Yong Huo
(First Hospital Peking University, People's Republic of China)

Suci Indriani
(National Cardiovascular Center Harapan Kita Hospital, Indonesia)

Yang-Soo Jang
(Bundang CHA Hospital, CHA College of Medicine, Korea)

Arun Kalyanasundaram
(Promed Hospital, India)

Do-Yoon Kang
(Seoul National University Hospital, Korea)

Jeehoon Kang
(Seoul National University Hospital, Korea)

Anek Kanoksilp
(Central Chest Institute of Thailand, Thailand)

Paul Hsien-Li Kao
(National Taiwan University Medical School & Hospital, Taiwan, R.O.C.)

Yu-Cheng Kao
(Chang Gung Memorial Hospital, Taiwan, R.O.C.)

P LN Kapardhi
(Care Hospitals, Hyderabad, India)

Wirash Kehasukcharoen
(Central Chest Institute of Thailand, Thailand)

Byeong Keuk Kim
(Yonsei University Severance Cardiovascular Hospital, Korea)

Hee-Yeol Kim
(The Catholic University of Korea, Bucheon St. Mary's Hospital, Korea)

Hyo-Soo Kim
(Seoul National University Hospital, Korea)

Kee-Sik Kim
(Daegu Catholic University Medical Center, Korea)

Moo Hyun Kim
(Dong-A University Medical Center, Korea)

Sang Wook Kim
(Chung-Ang University Hospital, Korea)

Tian Hai Koh
(National Heart Centre Singapore, Singapore)

Bon-Kwon Koo
(Seoul National University, Korea)

Po-Ming Ku
(Chi-Mei Medical Center, Liouying, Taiwan, R.O.C.)

A.V. Ganesh Kumar
(Dr. L. H. Hiranandani Hospital, India)

Feng Yu Kuo
(Kaohsiung Veterans General Hospital, Taiwan, R.O.C.)

Mohammad Kurdi
(Procare Riaya Hospital, Saudi Arabia)

Yovi Kurniawati
(National Cardiovascular Center Harapan Kita Hospital, Indonesia)

Chih-Hung Lai
(Taichung Veterans General Hospital, Taiwan, R.O.C.)

Chun-Wei Lee
(MacKay Memorial Hospital, Taiwan, R.O.C.)

Michael Lee
(Queen Elizabeth Hospital, Hong Kong)

Pil Hyung Lee
(Asan Medical Center, Korea)

Seung-Whan Lee
(Asan Medical Center, Korea)

Wen-Lieng Lee
(Taichung Veterans General Hospital, Taiwan, R.O.C.)

Cheng-Han Li
(National Cheng Kung University Hospital, Taiwan, R.O.C.)

Jianping Li
(Peking University First Hospital, People's Republic of China)

Weimin Li
(The First Affiliated Hospital of Harbin Medical University, People's Republic of China)

Yu Li
(Beijing Anzhen Hospital, Capital Medical University, People's Republic of China)

Yue Li
(The First Affiliated Hospital of Harbin Medical University, People's Republic of China)

Soo Teik Lim
(National Heart Centre of Singapore, Singapore)

Jiunn-Cherng Lin
(Chiayi Branch, Taichung Veterans General Hospital, Taiwan, R.O.C.)

Jun-Ting Liou
(China Medical University HsinChu Hospital, Taiwan, R.O.C.)

Shih-Chi Liu
(Fu Jen Catholic University Hospital, Taiwan, R.O.C.)

Sidney Tsz Ho Lo
(Liverpool Hospital, Australia)

Simon Lo
(Gleneagles Medical Center, Malaysia)

Adrian F. Low
(National University Heart Centre, Singapore)

Tse-Min Lu
(Taipei Veterans General Hospital, Taiwan, R.O.C.)

Jianfang Luo
(Guangdong Provincial People's Hospital, People's Republic of China)

Jianying Ma
(Zhongshan Hospital, People's Republic of China)

Arwin Saleh Mangkuanom
(National Cardiovascular Center Harapan Kita Hospital, Indonesia)

Kambis Mashayekhi
(Heartcenter Lahr, Germany)

Samuel K. Mathew
(Apollo Hospitals, India)

Ashwin B. Mehta
(Jaslok Hospital & Research Centre, India)

Sundeep Mishra
(NIMS, Jaipur, India)

Rosli Bin Mohd Ali
(National Heart Institute, Malaysia)

Muhammad Munawar
(Bina Waluya Hospital, Indonesia)

Chang Wook Nam
(Keimyung University Dongsan Hospital, Korea)

Chunhamaneewat Narathip
(Siriraj Hospital, Thailand)

Muenpetch Nuenkaew
(Thammasat University Hospital, Thailand)

Duk-Woo Park
(Asan Medical Center, Korea)

Hun Sik Park
(Kyungpook National University Hospital, Korea)

Seung-Jung Park
(Asan Medical Center, Korea)

M Reza Pasciolly
(Al Ihsan General Hospital, Indonesia)

Natarajapillai Prathap Kumar
(Meditrina Hospital, India)

Jie Qian
(Fu Wai Hospital, People's Republic of China)

V. Surya Prakasa Rao
(Care Hospitals, Hyderabad, India)

Sudhir Rathore
(Frimley Park Hospital NHS Trust, U.K.)

Hanumanth Reddy
(Care Hospitals, Hyderabad, India)

Nicolaus J. Reifart
(Main Taunus Heart Institute, Germany)

Seung-Woon Rha
(Cardiovascular Center, Korea University Guro Hospital, Korea)

Sodiqur Rifqi
(Dr. Kariadi General Hospital, Indonesia)

Stéphane Rinfret
(McGill University Health Centre, Canada)

M. Saifur Rohman
(Dr. Saiful Anwar General Hospital, Indonesia)

Sanjeeb Roy
(Manglamplus Medicity Hospital, Jaipur, India)

Teguh Santoso
(Medistra Hospital, Indonesia)

Priyen Kantilal Shah
(Care Hospitals, Hyderabad, India)

Owayed Al Shammeri
(Dr. Sulaiman Al Habib Hospital, Saudi Arabia)

Abdullah Shehab
(Burjeel Royal Hospital, UAE)

Georgios Sianos
(AHEPA University Hospital, Greece)

Andika Sitepu
(H. Adam Malik General Hospotal, Indonesia)

Mohamed Sobhy
(International Cardiac Center of Alexandria, Egypt)

Sunarya Soerianata
(Pondok Indah Hospital, Indonesia)

Jithendra Somaratne
(Auckland City Hospital, New Zealand)

V Sujatha
(Indus Hospitals, Visakhapatnam, Andhrapradesh, India)

Gautham Swaroop
(Apollomedics Super Speciality Hospitals, Lucknow, India)

Khalid Tammam
(International Medical Center, Jeddah, Saudi Arabia)

Cheng-Ting Tsai
(MacKay Memorial Hospital, Taiwan, R.O.C.)

Rajesh Vijayvergia
(PGIMER, Chandigarh, India)

Yu-Chen Wang
(Asia University Hospital, Taiwan, R.O.C.)

Cheng-Chun Wei
(Shin Kong Memorial Hospital, Taiwan, R.O.C.)

Gerald S. Werner
(Klinikum Darmstadt, Germany)

Chiung-Jen Wu
(Kaohsiung Chang Gung Memorial Hospital, Taiwan, R.O.C.)

Eugene Brian Wu
(Prince of Wales Hospital, Hong Kong)

Mike Wyman
(Torrance Memorial, USA)

Bo Xu
(Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, People's Republic of China)

Achmad Fauzi Yahya
(Hasan Sadikin Gospital, Indonesia)

Hongbing Yan
(Fu Wai Hospital, National Center for Cardiovascular Diseases, People's Republic of China)

Jong-Shiuan Yeh
(Taipei Municipal Wanfang Hospital, Taiwan, R.O.C.)

Andy Yong
(Concord Repatriation Hospital, Royal Prince Alfred Hospita, Australia)

Hyuck-Jun Yoon
(Dongsan Hospital, Keimyung University, Korea)

Young Won Yoon
(Gangnam Severance Hospital, Korea)

Bin Zhang
(Guangdong Provincial Cardiovascular Institute, People's Republic of China)

Damodharan
(Apollo Hospitals, Chennai, India)

CCT Administration Office
Central Residence 201, 48 Higashiodawaracho, Toyohashi, Aichi 440-0886, Japan
TEL:+81-532-57-1275 / FAX:+81-532-52-2883 / E-mail: secretariat@cct.gr.jp / Find Us on